Retraction Retraction dated 2024-06-26
Click to view Retraction: https://doi.org/10.1038/s41586-024-07656-x
-
Authors
Poore, Gregory D.
Kopylova, Evguenia
Zhu, Qiyun https://orcid.org/0000-0002-3568-6271
Carpenter, Carolina
Fraraccio, Serena
Wandro, Stephen
Kosciolek, Tomasz https://orcid.org/0000-0002-9915-7387
Janssen, Stefan https://orcid.org/0000-0003-0955-0589
Metcalf, Jessica
Song, Se Jin https://orcid.org/0000-0003-0750-5709
Kanbar, Jad
Miller-Montgomery, Sandrine
Heaton, Robert
Mckay, Rana
Patel, Sandip Pravin
Swafford, Austin D.
Knight, Rob https://orcid.org/0000-0002-0975-9019
- License Information
-
More Information
Article History
Received: 7 June 2019
Accepted: 6 February 2020
First Online: 11 March 2020
Change Date: 7 February 2024
Change Type: Update
Change Details: Editor’s Note: Readers are alerted that concerns have been raised about the data and conclusions presented in this article. Further editorial action will be taken once this matter has been resolved.
Change Date: 26 June 2024
Change Type: Correction
Change Details: This article has been retracted. Please see the Retraction Notice for more detail:
Change Details: https://doi.org/10.1038/s41586-024-07656-x
Competing interests
: Clarity Genomics, the employer of E.K., did not provide funding for this study. G.D.P. and R.K. have jointly filed U.S. Provisional Patent Application Serial No. 62/754,696 and International Application No. PCT/US19/59647 on the basis of this work. G.D.P., R.K., and S.M.-M. have started a company to commercialize the intellectual property. R.K. is a member of the scientific advisory board for GenCirq, holds an equity interest in GenCirq, and can receive reimbursements for expenses up to US$5,000 per year. R.K., A.D.S., and S.M.-M. are directors at the Center for Microbiome Innovation at UC San Diego, which receives industry research funding for various microbiome initiatives, but no industry funding was provided for this cancer microbiome project.
